Read the current Defeat Diabetes® E-Lerts™ Newsletter

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

 
 
 
     
Rewarding for
you and us

Defeat Diabetes Foundation
    
      
       
Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300

Madeira Beach, FL 33708
  

Research » Type 2

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Scientists Turn Human Skin Cells Into Insulin-producing Cells
Posted: Wednesday, September 24, 2008
Researchers at the University of North Carolina at Chapel Hill School of Medicine have transformed cells from human skin into cells that produce insulin, the same hormone used to treat diabetes.

Exercise Reduces Fat In Livers of Diabetics: Study
Posted: Wednesday, September 24, 2008
Regular moderate exercise helps people with diabetes to reduce fat in their livers, in turn potentially preventing liver failure and heart disease, said U.S. researchers.

Pre-Meal Blood Glucose Values Best Gauge of True HbA1c
Posted: Wednesday, September 24, 2008
For patients with type 1 or type 2 diabetes, pre-prandial glucose levels are generally more closely associated with long-term HbA1c levels than post-prandial glucose levels, according to a new study.

EASD: Byetta Wins In Head to Head Trial Over Januvia In Postprandial Glucose
Posted: Wednesday, September 17, 2008
In a month-long head-to-head trial, the incretin mimetic exenatide (Byetta) reduced postprandial glucose in type 2 diabetes more than did sitagliptin (Januvia), an oral DPP-4 inhibitor, researchers reported.

EASD: Cardiovascular Risk Factors Prevalent in Type 2 Diabetic Adolescents
Posted: Wednesday, September 17, 2008
Adolescents and young adults with type 2 diabetes are more likely to have hypertension, generalized obesity, abdominal obesity, low HDL cholesterol, high triglycerides and microalbuminuria, than their non-diabetic counterparts.


New Gastrointestinal Treatment For Diabetes Using the EndoBarrier Liner
Posted: Wednesday, September 17, 2008
GI Dynamics announces data demonstrating immediate and sustained reduction in HbA1c in patients with type 2 diabetes using EndoBarrier® Gastrointestinal Liner. Compelling clinical data highlighted at first World Congress on Interventional Therapies for Type 2 Diabetes show improved glycemic control and weight reduction in uncontrolled diabetics.

EASD: Early Intensive Glucose Control Pays Dividends
Posted: Wednesday, September 17, 2008
A 10-year follow-up of a landmark trial of intensive glucose control in type 2 diabetes has suggested that the clinical benefit was more than durable and rose over time to a reduction or 15% for myocardial infarction and a 13% reduction in the relative risk of death from any cause.

New Analysis Shows Lower Not Necessarily Better When It Comes to BP
Posted: Wednesday, September 10, 2008
New observational analysis of the ONTARGET study shows that lower is not necessarily better when it comes to blood pressure in this patient population, with coronary heart disease or diabetes plus additional risk factors. Although there was evidence that lower was better in terms of stroke, there was a suggestion of harm when BP was reduced below 130 mm Hg systolic for the outcome of cardiovascular death in diabetics. The findings suggest that in high-risk people, the [current] guidelines of 'the lower, the better' may not apply.

Januvia/Byetta Becoming First and Second-Line Therapy for Type 2 Diabetes
Posted: Wednesday, September 10, 2008
New research reports that Januvia is currently prescribed most often as a third- or later-line of therapy for the treatment of type 2 diabetes.

Normal Weight Obesity: A Real Health Risk
Posted: Wednesday, September 10, 2008
Normal weight obesity isn't an oxymoron. "The definition of obesity is having excess fat, not excess weight.

Page 74 of 129
 |<   <<   <  69  |  70  |  71  |  72  |  73  |  74  |  75  |  76  |  77  |  78  |  79  >   >>   >| 

 
 
 
 
 
Join us on Facebook
 
 
 
 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.  
 
 

Send your unopened, unexpired test strips to:


Defeat Diabetes Foundation
150 153rd Ave, Suite 300
Madeira Beach, FL 33708

 

DDF advertisement
 

 Friendly Banner
 


Friendly Banner
 
 
 
Analyze nutrition content by portion
DDF advertisement